RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fresenius SE & Co KGaA Stock

Fresenius SE & Co KGaA Net Income 2025

Fresenius SE & Co KGaA Net Income

1.9 B EUR

Ticker

FRE.DE

ISIN

DE0005785604

WKN

578560

In 2025, Fresenius SE & Co KGaA's profit amounted to 1.9 B EUR, a 17.17% increase from the 1.62 B EUR profit recorded in the previous year.

The Fresenius SE & Co KGaA Net Income history

YEARNET INCOME (undefined EUR)
2029e-
2028e2.72
2027e2.45
2026e2.12
2025e1.9
2024e1.62
2023-0.59
20221.37
20211.82
20201.71
20191.88
20182.03
20171.81
20161.56
20151.39
20141.07
20130.99
20120.93
20110.69
20100.62
20090.48
20080.53
20070.42
20060.33
20050.22
20040.17

Fresenius SE & Co KGaA Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Fresenius SE & Co KGaA, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Fresenius SE & Co KGaA from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Fresenius SE & Co KGaA’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Fresenius SE & Co KGaA. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Fresenius SE & Co KGaA’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Fresenius SE & Co KGaA’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Fresenius SE & Co KGaA’s growth potential.

Fresenius SE & Co KGaA Revenue, EBIT and net profit per share

DateFresenius SE & Co KGaA RevenueFresenius SE & Co KGaA EBITFresenius SE & Co KGaA Net Income
2029e28.81 B undefined0 undefined0 undefined
2028e27.06 B undefined3.52 B undefined2.72 B undefined
2027e25.2 B undefined3.28 B undefined2.45 B undefined
2026e24.11 B undefined2.87 B undefined2.12 B undefined
2025e23 B undefined2.62 B undefined1.9 B undefined
2024e21.89 B undefined2.36 B undefined1.62 B undefined
202322.3 B undefined1.2 B undefined-594 M undefined
202221.53 B undefined1.84 B undefined1.37 B undefined
202137.52 B undefined4.18 B undefined1.82 B undefined
202036.28 B undefined4.36 B undefined1.71 B undefined
201935.41 B undefined4.63 B undefined1.88 B undefined
201833.53 B undefined4.45 B undefined2.03 B undefined
201733.89 B undefined4.56 B undefined1.81 B undefined
201629.47 B undefined4.33 B undefined1.56 B undefined
201528 B undefined3.94 B undefined1.39 B undefined
201423.46 B undefined3.12 B undefined1.07 B undefined
201320.55 B undefined2.99 B undefined988 M undefined
201219.51 B undefined2.99 B undefined930 M undefined
201116.52 B undefined2.56 B undefined690 M undefined
201015.97 B undefined2.42 B undefined619 M undefined
200914.17 B undefined2.05 B undefined475 M undefined
200812.35 B undefined1.76 B undefined528 M undefined
200711.39 B undefined1.65 B undefined422 M undefined
200610.78 B undefined1.44 B undefined330 M undefined
20057.89 B undefined969 M undefined222 M undefined
20047.27 B undefined845 M undefined168 M undefined

Fresenius SE & Co KGaA stock margins

The Fresenius SE & Co KGaA margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fresenius SE & Co KGaA. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fresenius SE & Co KGaA.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Fresenius SE & Co KGaA's sales revenue. A higher gross margin percentage indicates that the Fresenius SE & Co KGaA retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Fresenius SE & Co KGaA's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Fresenius SE & Co KGaA's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Fresenius SE & Co KGaA's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Fresenius SE & Co KGaA. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Fresenius SE & Co KGaA's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Fresenius SE & Co KGaA Margin History

Fresenius SE & Co KGaA Gross marginFresenius SE & Co KGaA Profit marginFresenius SE & Co KGaA EBIT marginFresenius SE & Co KGaA Profit margin
2029e22.68 %0 %0 %
2028e22.68 %13.02 %10.05 %
2027e22.68 %13.01 %9.73 %
2026e22.68 %11.88 %8.79 %
2025e22.68 %11.37 %8.25 %
2024e22.68 %10.79 %7.4 %
202322.68 %5.36 %-2.66 %
202225.09 %8.53 %6.37 %
202127.48 %11.14 %4.85 %
202028.44 %12.02 %4.71 %
201929.22 %13.07 %5.32 %
201829.33 %13.27 %6.05 %
201730.96 %13.47 %5.35 %
201632.28 %14.69 %5.29 %
201531.87 %14.08 %4.95 %
201430.15 %13.3 %4.56 %
201332.13 %14.55 %4.81 %
201233.37 %15.32 %4.77 %
201134.13 %15.51 %4.18 %
201033.33 %15.17 %3.88 %
200932.79 %14.47 %3.35 %
200831.92 %14.25 %4.27 %
200732.52 %14.46 %3.7 %
200631.89 %13.39 %3.06 %
200534.09 %12.28 %2.81 %
200432.68 %11.62 %2.31 %

Fresenius SE & Co KGaA Aktienanalyse

What does Fresenius SE & Co KGaA do?

Fresenius SE is a German pharmaceutical and medical technology company, which was founded in 1912 by Eduard Fresenius. The company's history is marked by continuous growth and numerous acquisitions, which have shaped the current corporate structure. Fresenius operates in four different divisions: Fresenius Medical Care is a global leader in dialysis treatment and offers products as well as services related to dialysis. Fresenius Kabi specializes in the production of medications and medical devices for infusion and nutrition therapy. Fresenius Helios is one of the largest providers of hospital treatments with over 110 clinics and operates facilities in Germany, Spain, and Latin America. Fresenius Vamed offers services related to the management and planning of healthcare facilities and operates worldwide in over 85 countries. The business model of Fresenius SE is based on the development and production of innovative medical products, as well as the provision of services in the healthcare sector. The company relies on high-quality products and intensive research and development. A key factor for success is focusing on the needs of customers and patients to ensure the best possible care. One of the most well-known products of Fresenius SE are the Fresenius concentrates for dialysis treatment. These enable effective and gentle blood cleansing, thereby improving the quality of life for dialysis patients. Another example of innovative products are the 3-in-1 infusion systems by Fresenius Kabi. These combine the administration of fluids, medications, and nutrition into one system, offering significantly higher efficiency in patient care. Fresenius Helios focuses on patient-centered care and offers a wide range of medical services. The company operates both acute care clinics and long-term care facilities and utilizes state-of-the-art technologies to improve diagnosis and treatment. Fresenius Vamed provides its customers with services such as facility management, planning, and project management for healthcare facilities, as well as operational consulting. The comprehensive expertise in all areas of the healthcare industry ensures high quality in the implementation of construction projects and renovations. In summary, Fresenius SE is an internationally active company specializing in the provision of high-quality products and services in the healthcare sector. The company focuses on patient-centered care and the continuous development of innovative products and technologies. Fresenius SE & Co KGaA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Fresenius SE & Co KGaA revenue by segment

  • 26 % Helios

  • 19 % Kabi

  • 5 % Vamed

  • 50 % Medical Care

Net Income Details

Understanding Fresenius SE & Co KGaA's Profit Margins

The profit margins of Fresenius SE & Co KGaA represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Fresenius SE & Co KGaA's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Fresenius SE & Co KGaA's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Fresenius SE & Co KGaA's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Fresenius SE & Co KGaA’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Fresenius SE & Co KGaA stock

How much profit has Fresenius SE & Co KGaA made this year?

Fresenius SE & Co KGaA has made 1.9 B EUR this year.

How has the profit developed compared to last year?

The profit has increased by 17.17% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Fresenius SE & Co KGaA publish its earnings?

Fresenius SE & Co KGaA publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Fresenius SE & Co KGaA?

The profits of Fresenius SE & Co KGaA are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Fresenius SE & Co KGaA?

You can learn more about the earnings of Fresenius SE & Co KGaA by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Fresenius SE & Co KGaA pay?

Over the past 12 months, Fresenius SE & Co KGaA paid a dividend of 0.92 EUR . This corresponds to a dividend yield of about 2.53 %. For the coming 12 months, Fresenius SE & Co KGaA is expected to pay a dividend of 0.96 EUR.

What is the dividend yield of Fresenius SE & Co KGaA?

The current dividend yield of Fresenius SE & Co KGaA is 2.53 %.

When does Fresenius SE & Co KGaA pay dividends?

Fresenius SE & Co KGaA pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Fresenius SE & Co KGaA?

Fresenius SE & Co KGaA paid dividends every year for the past 0 years.

What is the dividend of Fresenius SE & Co KGaA?

For the upcoming 12 months, dividends amounting to 0.96 EUR are expected. This corresponds to a dividend yield of 2.64 %.

In which sector is Fresenius SE & Co KGaA located?

Fresenius SE & Co KGaA is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fresenius SE & Co KGaA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fresenius SE & Co KGaA from 5/22/2023 amounting to 0.92 EUR, you needed to have the stock in your portfolio before the ex-date on 5/18/2023.

When did Fresenius SE & Co KGaA pay the last dividend?

The last dividend was paid out on 5/22/2023.

What was the dividend of Fresenius SE & Co KGaA in the year 2024?

In the year 2024, Fresenius SE & Co KGaA distributed 0.92 EUR as dividends.

In which currency does Fresenius SE & Co KGaA pay out the dividend?

The dividends of Fresenius SE & Co KGaA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Fresenius SE & Co KGaA stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Fresenius SE & Co KGaA

Our stock analysis for Fresenius SE & Co KGaA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fresenius SE & Co KGaA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.